Study reveals that many with an increased risk of cancer were excluded from the potential for monitoring More: NHS gene testing fails half of people at cancer risk Source: News
read moreSandoz launches generic Revlimid in 19 countries in Europe, opening a flood of competition for BMS’ megablockbuster kdunleavy Fri, 02/18/2022 – 11:17 More: Sandoz launches generic Revlimid in 19 countries in Europe, opening a flood of competition for BMS' megablockbuster
read moreRoche settles lawsuit claiming AstraZeneca’s Ultomiris infringes delivery patent aliu Fri, 02/18/2022 – 09:51 More: Roche settles lawsuit claiming AstraZeneca’s Ultomiris infringes delivery patent Source: fierce
read moreSanofi, Regeneron ditch Dupixent trial in patients who failed Novartis and Roche’s Xolair for hives condition kdunleavy Fri, 02/18/2022 – 09:50 More: Sanofi, Regeneron ditch Dupixent trial in patients who failed Novartis and Roche's Xolair for hives condition Source: fierce
read moreRecipharm, working on Moderna’s COVID vaccine, boosts biologics presence with Arranta Bio, Vibalogics buyouts fkansteiner Fri, 02/18/2022 – 09:47 More: Recipharm, working on Moderna's COVID vaccine, boosts biologics presence with Arranta Bio, Vibalogics buyouts Source: fierce
read moreJ&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn’s data fkansteiner Fri, 02/18/2022 – 07:52 More: J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn's data Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals